TTY Biopharm
TTY Biopharm
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluating the Treatment Outcomes of Tafasitamab in Patients With Relapsed/ Refractory Diffuse Large B-cell Lymphoma: a Real-world Evidence Study | diffuse large B-cell lymphoma | Active, not recruiting | Not stated | 2026-07-16 | NCT07709624 | |
| Phase II Study of Ultrasound and ctDNA Guided Neoadjuvant Systemic Therapy for Patients With HER2-positive Early Breast Cancer (UC HER Trial) | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Not yet recruiting | Phase 2 | 2026-05-04 | NCT07565324 | |
| A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfonate in Patients With Carbapenem-Resistant Gram-Negative Bacterial Infection | Bacterial Infections and Mycoses, Infections, bacterial infectious disease, bacterial pneumonia, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Not stated | 2026-03-09 | NCT06966284 |